Systems and methods for mechanogenetic functional ultrasound imaging
US-12172037-B2 · Dec 24, 2024 · US
US10172332B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10172332-B2 |
| Application number | US-201615076836-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 22, 2016 |
| Priority date | Sep 29, 2010 |
| Publication date | Jan 8, 2019 |
| Grant date | Jan 8, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a method for regenerating hair follicles by transplanting a composition containing CD36-expressing dermal sheath cells (DSc) to a human. The composition may be prepared by sorting CD36-expressing dermal sheath cells from a hair follicle tissue by use of a cell-sorting technique along with an antibody to CD36. The composition may also contain dermal papilla cells (DPc).
Opening claim text (preview).
The invention claimed is: 1. A method for regenerating hair follicles, comprising the step of transplanting a composition comprising CD36-expressing human dermal sheath cells to human skin, wherein the hair follicles are regenerated. 2. The method of claim 1 , wherein said composition is prepared by a process comprising the step of sorting CD36-expressing human dermal sheath cells from a human hair follicle tissue by use of a cell sorting technique using an antibody to CD36. 3. The method of claim 2 , wherein said composition further comprises human dermal papilla cells. 4. The method of claim 3 , wherein the ratio of the number of said CD36-expressing human dermal sheath cells to the number of said human dermal papilla cells is about 10:1 to 1:10. 5. The method of claim 1 , wherein said composition further comprises human dermal papilla cells. 6. The method of claim 5 , wherein the ratio of the number of said CD36-expressing human dermal sheath cells to the number of said human dermal papilla cells is about 10:1 to 1:10. 7. A method for regenerating hair follicles, comprising the steps of: preparing a composition comprising CD36-expressing human dermal sheath cells; and transplanting said composition to human skin, wherein the hair follicles are regenerated. 8. The method of claim 7 , wherein said composition is prepared by a process comprising the step of sorting CD36-expressing human dermal sheath cells from a human hair follicle tissue by use of a cell sorting technique using an antibody to CD36. 9. The method of claim 8 , wherein said composition further comprises human dermal papilla cells. 10. The method of claim 9 , wherein the ratio of the number of said CD36-expressing human dermal sheath cells to the number of said human dermal papilla cells is about 10:1 to 1:10. 11. The method of claim 7 , wherein said composition further comprises human dermal papilla cells. 12. The method of claim 11 , wherein the ratio of the number of said CD36-expressing human dermal sheath cells to the number of said human dermal papilla cells is about 10:1 to 1:10.
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Animal model, e.g. for test or diseases · CPC title
Hair cells · CPC title
Hair stem cells; Hair progenitors (mesenchymal stem cells from hair follicles C12N5/0666) · CPC title
Chimeric vertebrates, e.g. comprising exogenous cells · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.